180 related articles for article (PubMed ID: 35932758)
21. Enhanced in vitro cytotoxicity and antitumor activity in vivo of iridium(III) complexes liposomes targeting endoplasmic reticulum and mitochondria.
Li W; Wu X; Liu H; Shi C; Yuan Y; Bai L; Liao X; Zhang Y; Liu Y
J Inorg Biochem; 2022 Aug; 233():111868. PubMed ID: 35636300
[TBL] [Abstract][Full Text] [Related]
22. Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway.
Wang J; Liu H; Wu X; Shi C; Li W; Yuan Y; Liu Y; Xing D
J Biol Inorg Chem; 2022 Aug; 27(4-5):455-469. PubMed ID: 35817878
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
[TBL] [Abstract][Full Text] [Related]
24. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
[TBL] [Abstract][Full Text] [Related]
25. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L
Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038
[TBL] [Abstract][Full Text] [Related]
26. Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis.
Huang C; Yuan Y; Li G; Tian S; Hu H; Chen J; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116112. PubMed ID: 38183779
[TBL] [Abstract][Full Text] [Related]
27. Anticancer effect evaluation of iridium(III) complexes targeting mitochondria and endoplasmic reticulum.
Wang Y; Li Y; Chen J; Liu H; Zhou Y; Huang C; Liang L; Liu Y; Wang X
J Inorg Biochem; 2023 Jan; 238():112054. PubMed ID: 36335745
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of iridium(III) complexes on antineoplastic activity against human gastric carcinoma SGC-7901 cells.
Tian L; Zhang Y; Zhang H; Zhou Y; Li W; Yuan Y; Hao J; Yang L; Liu Y
J Biol Inorg Chem; 2021 Sep; 26(6):705-714. PubMed ID: 34448071
[TBL] [Abstract][Full Text] [Related]
29. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
30. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
31. Brominated cyclometalated iridium(III) complexes for mitochondrial immobilization as potential anticancer agents.
Liu B; Chen Z; Li Y; Du XF; Zhang W; Zhang W; Lai Y; Li Y
Dalton Trans; 2022 May; 51(19):7650-7657. PubMed ID: 35510904
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
33. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
[TBL] [Abstract][Full Text] [Related]
34. Targeted liposomes encapsulated iridium(III) compound greatly enhance anticancer efficacy and induce cell death via ferroptosis on HepG2 cells.
Chen J; Li W; Li G; Liu X; Huang C; Nie H; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116078. PubMed ID: 38141286
[TBL] [Abstract][Full Text] [Related]
35. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of iridium(III) complexes as potential antitumor agents.
Du F; Bai L; He M; Zhang WY; Gu YY; Yin H; Liu YJ
J Inorg Biochem; 2019 Dec; 201():110822. PubMed ID: 31536949
[TBL] [Abstract][Full Text] [Related]
37. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z
J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884
[TBL] [Abstract][Full Text] [Related]
38. Liposome as drug delivery system enhance anticancer activity of iridium (III) complex.
Gu Y; Bai L; Zhang Y; Zhang H; Xing D; Tian L; Zhou Y; Hao J; Liu Y
J Liposome Res; 2021 Dec; 31(4):342-355. PubMed ID: 32892672
[TBL] [Abstract][Full Text] [Related]
39. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
[TBL] [Abstract][Full Text] [Related]
40. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
